Biological imaging in radiation oncology

Keyphrases

• Biological Imaging 100%
• Radiation Oncology 100%
• Therapy Response 100%
• Tumor 66%
• Single-photon Emission Computed Tomography (SPECT) 66%
• Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) 66%
• Cervical Carcinoma 66%
• Bronchioloalveolar Carcinoma 66%
• Esophageal Squamous Cell Carcinoma 66%
• Radiation Treatment Planning 66%
• Cell Proliferation 33%
• Gene Expression 33%
• Amino Acids 33%
• Prostate Cancer 33%
• Image Fusion 33%
• Hypoxia 33%
• Brain Tumor 33%
• Anatomical Imaging 33%
• CT-MRI 33%
• Dose Distribution 33%
• Dose Painting 33%
• Proliferation Apoptosis 33%
• Tumor Mass 33%
• Treatment Monitoring 33%
• Tumor-related Genes 33%
• Radiochemotherapy 33%
• Tumor Angiogenesis 33%
• Gross Tumor Volume 33%
• Planning Target Volume 33%
• Volume-targeted 33%
• Imaging CT 33%

Medicine and Dentistry

• Magnetic Resonance Imaging 100%
• Treatment Response 100%
• Radiation Oncology 100%
• Polyethylene Terephthalate 100%
• Neoplasm 66%
• Clinical Study 66%
• Single-Photon Emission Computed Tomography 66%
• Uterine Cervix Carcinoma 66%
• Lung Carcinoma 66%
• Tumor 66%
• Esophagus Carcinoma 66%
• Radiation Treatment Planning 66%
• Positron Emission Tomography 33%
• Gene Expression 33%
• Amino Acid 33%
• Cell Proliferation 33%
• Programmed Cell Death 33%
• Sensitivity and Specificity 33%
• Prostate Cancer 33%
• Patient Monitoring 33%
• Hypoxia 33%
• Chemoradiotherapy 33%
• Intensity Modulated Radiation Therapy 33%
• Tumor Angiogenesis 33%
• Intracranial Tumor 33%
• Dose Distribution 33%
• CT 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Polyethylene Terephthalate 100%
• Neoplasm 75%
• Clinical Study 50%
• Uterine Cervix Carcinoma 50%
• Lung Carcinoma 50%
• Esophagus Carcinoma 50%
• Amino Acid 25%
• Prostate Cancer 25%
• Hypoxia 25%
• Intracranial Tumor 25%